E. Ohman J or Asset Management AB Sells 6,200 Shares of The Procter & Gamble Company (NYSE:PG)

E. Ohman J or Asset Management AB lowered its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 6.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,756 shares of the company’s stock after selling 6,200 shares during the period. E. Ohman J or Asset Management AB’s holdings in Procter & Gamble were worth $16,585,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Acorn Creek Capital LLC increased its position in shares of Procter & Gamble by 2.8% during the 3rd quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company’s stock valued at $376,000 after purchasing an additional 59 shares during the last quarter. Patrick M Sweeney & Associates Inc. raised its stake in shares of Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company’s stock worth $963,000 after acquiring an additional 59 shares in the last quarter. Alera Investment Advisors LLC lifted its holdings in shares of Procter & Gamble by 1.2% in the 1st quarter. Alera Investment Advisors LLC now owns 5,007 shares of the company’s stock worth $812,000 after acquiring an additional 60 shares during the last quarter. Hudson Value Partners LLC boosted its stake in shares of Procter & Gamble by 4.1% in the 2nd quarter. Hudson Value Partners LLC now owns 1,516 shares of the company’s stock valued at $250,000 after purchasing an additional 60 shares in the last quarter. Finally, Traveka Wealth LLC raised its position in Procter & Gamble by 1.7% in the 3rd quarter. Traveka Wealth LLC now owns 3,554 shares of the company’s stock worth $616,000 after purchasing an additional 60 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Trading Up 0.0 %

Shares of NYSE PG opened at $169.64 on Friday. The Procter & Gamble Company has a 1 year low of $142.50 and a 1 year high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm has a 50-day moving average of $171.88 and a 200 day moving average of $167.45. The stock has a market cap of $399.51 billion, a P/E ratio of 29.25, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the firm posted $1.83 EPS. The business’s revenue for the quarter was down .6% compared to the same quarter last year. As a group, sell-side analysts expect that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.37%. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Wall Street Analyst Weigh In

PG has been the topic of a number of recent research reports. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Morgan Stanley boosted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday. Barclays cut shares of Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 target price on the stock. in a report on Monday, September 30th. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Finally, TD Cowen began coverage on shares of Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $177.00.

Get Our Latest Analysis on Procter & Gamble

Insider Activity at Procter & Gamble

In related news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $170.00, for a total value of $573,410.00. Following the transaction, the chief executive officer now owns 21,513 shares in the company, valued at $3,657,210. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Balaji Purushothaman sold 8,842 shares of the business’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now owns 11,537 shares of the company’s stock, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 385,186 shares of company stock valued at $65,479,358. 0.18% of the stock is owned by corporate insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.